Complete synthesis of 3′-sialyl-N-acetyllactosamine by regioselective transglycosylation  by Vetere, Amedeo & Paoletti, Sergio
FEBS 17879 FEBS Letters 399 (1996) 203-206 
Complete synthesis of 3'-sialyl-N-acetyllactosamine by 
regioselective transglycosylation 
Amedeo Vetere*, Sergio Paoletti 
Dipartimento di Biochimica, Biofisiea e Chimica delle Macromolecole, Universith degli Studi di Trieste, Via L. Giorgieri 1, 1-34127 Trieste, Italy 
Received 20 September 1996: revised version received 21 October 1996 
~.bstract Transglycolytic synthesis of 3'-sialyl-N-acetyllactos- 
amine by sequential use of ~-galactosidase from Bacillus 
~'irculans and trans-sialidase from Trypanosoma cruzi was 
described. These reactions depicted the first complete synthesis 
of a biologically important oligosaccbaride with high regioselec- 
fivity avoiding use of glycosyltransferases and NDP sugars. 
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I. Introduction 
Sialylated oligosaccharides participate in many important 
)iological events. Mainly as components of glycoproteins 
md glycolipids, they act as antigenic determinants, receptors 
"or proteins, viruses or bacteria and mediate cell-cell recogni- 
ion and interactions [1,2]. In particular, the trisaccharide 3'- 
dalyl-N-acetyllactosamine (3'-SLN) has been found in free 
"orm in normal and pathological human urine and in human 
nilk where it plays an important biological role [3 5]. 
Furthermore, c~-(1,3)-fucosylation at the D-GlcpNAc residue 
~f 3'-SLN gives sialyl-Lewis x, identified as a functional igand 
"or E-, P- and L-selectin. It mediates trafficking and recruit- 
nent of blood-borne leukocytes to endothelial cells during 
aormal and pathological inflammatory responses to injury 
md infection [6,7]. The multi-step chemical synthesis of this 
~iologically important trisaccharide has been described [8], 
9ut it is very laborious. In order to avoid multi-step chemical 
~ynthesis, enzymatic methods have been developed using gly- 
-osyltransferases a catalysts [9-11]. Moreover, the latter en- 
zymes require activated sugars which, in spite of recent im- 
igrovements in production by biochemical recycling [12], still 
ire costly and industrially non-attractive substrates. 
In the present work we report the first complete synthesis of 
V-SLN by exclusive use of transglycosylation activities of 
Bacillus circulans [3-galactosidase and Trypanosoma cruzi 
:rans-sialidase. 
2. Materials and methods 
2.1. Materials 
Lactose, D-GlcpNAc, 3'-N-acetylneuraminyl-lactose (3'-sialyllac- 
rose) and 2-(4-methylumbelliferyl)-Ct-D-N-acetylneuraminic acid 
(MU-NeuAc) were purchased from Sigma (St. Louis, MO, USA). 
3'-SLN was from Dextra Laboratories Ltd (Reading, UK). 
[14C]Lactose (50 laCk 60 mCi/mmol) was from Amersham (Buckin- 
ghamshire, UK). 13-Galactosidase from B. cireulans was a kind gift of 
Daiwa Kasei Co. (Osaka, Japan). E. coli strain carrying plasmid 
pTS154cat containing the gene for 72 cruzi trans-sialidase was a 
kind gift of Dr. Dan Eichinger (Department of Medical and Molecu- 
lar Parasitology, New York University School of Medicine). Bio-Gel 
P2 was from Bio-Rad (Richmond, CA, USA). QAE-Sephadex A25 
was from Pharmacia-Biotech (Uppsala, Sweden). Ni-agarose was 
from QIAGEN (Hilden, Germany). Centriflo membrane cones CF25 
were from Amicon (Beverly, MA, USA). Sep-Pak C18 cartridge were 
from Waters (Milford, MA, USA). LiChrosorb-NH2 HPLC column 
and TLC Silica Gel 60 plates were from Merck (Darmstadt, Ger- 
many). All other chemicals were of analytical grade. 
2.2. Preparation of 72 cruzi trans-sialidase 
Extensive information on the enzymatic haracterization f the T 
cruzi trans-sialidase is given elsewhere [13,14]. 
E. coli strain carrying plasmid pTS 154cat containing the gene for T. 
cruzi trans-sialidase was grown, induced and pelleted as described [15]. 
Bacterial lysis and enzyme purification were performed according to 
the following partly original procedure, which nevertheless i  based on 
published methods [15,16]. The cells were resuspended in 1 ml of 
permeabilization buffer consisting of 100 mM Tris-HCl pH 7.8 con- 
taining 32 mM NaH2PO4 and 4% v/v of Triton X-100. Lysis was 
carried out by adding polymyxin B sulfate to give a final concentra- 
tion of 200 lag/ml. After incubation for 30 min at room temperature 
and 30 min on ice, insoluble debris was pelleted and imidazole was 
added to the supernatant to a final concentration of 10 mM. Purifica- 
tion of trans-sialidase was carried out on a column of Ni-agarose 
(1.2× 2 cm) equilibrated with 100 mM Tris-HCl pH 7.8 containing 
32 mM NaH2PO4 and 10 mM imidazole. After washing with this 
buffer, the enzyme was eluted in steps, with 10x 1 ml of PBS contain- 
ing imidazole 33 mM, 67 mM, 125 mM and 250 mM, respectively. 
Each fraction collected was analyzed for enzyme activity, which re- 
vealed that only the fractions corresponding to the elution with an 
imidazole concentration of 67 and 125 mM were active. SDS-PAGE 
of the two fractions confirmed that each of them contained a single 
protein band. The active fractions were pooled and the volume re- 
duced by centrifugation on a Centriflo membrane cone CF25. 
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2.3. Assay of 72 cruzi trans-sialidase 
Enzymatic activity was assayed according to the procedure reported 
in [17], which had been demonstrated to ensure linearity between 
reaction velocity and amount of enzyme. Occasional modification of 
the previous procedure to follow that reported in [14], i.e. increasing 
the concentration of [14C]lactose by a factor 10, did not impair the 
previous conclusions about enzymatic activity. 
4bbreviations: NDP sugars, nucleoside diphosphate sugars; 3'-SLN, 
Y-sialyl-N-acetyllactosamine; D-GlcpNAc, 2-acetamido-2-deoxy-D- 
glucopyranose; D-Glcp, D-glucopyranose; BcG, B. circulans 9- 
galactosidase; TcTs, 72 cruzi trans-sialidase; [14C]lactose, [D-(glu- 
cose)-l-14C]lactose; PBS, phosphate buffer saline; MU-NeuAc, 2-(4- 
rnethylumbelliferyl)-Ct-D-N-acetylneuraminic acid; MU, 4-methylum- 
belliferone 
2.4. Synthesis of N-acetyllactosamine 
Regioselective synthesis of N-acetyllactosamine was obtained from 
lactose as donor, D-GlcpNAc as acceptor and 13-galactosidase from B. 
eireulans as the transglycosylating enzyme as described in [18]. 
2.5. Sialylation us&g 3'-s&lyllactose as donor 
Equimolar quantities (7.8 ~axlol) of 3'-sialyllactose and N-acetyllac- 
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Fig. 1. Schematic representation f the synthesis of Y-SLN. BcG: B. circulans 13-galactosidase; TcTs: T. cruzi trans-sialidase. 
tosamine were dissolved in 400 Ixl of 100 mM PBS, pH 7.2 containing 
0.2% of BSA, then 13 U (100 lal) of T. cruzi trans-sialidase were 
added. After incubation for 24 h at 37°C the mixture was heated in 
a boiling water bath for 10 min and then immediately cooled in ice. 
After centrifugation at 11 000 rpm for 5 min, the clear supernatant 
was diluted 20 times with water and applied on a column of QAE- 
Sephadex A25 (15 × 1.5 cm) equilibrated in water. Elution by washing 
was performed with water for neutral compounds and with 1 M 
ammonium formate for sialylated compounds. Elution was followed 
by TLC developed with n-propanol/1 N ammonia/water (6:2:1) and 
detected with 0.2% orcinol in 2 M H2SO 4. Fractions containing 3'- 
sialyllactose and 3'-SLN were pooled and concentrated under va- 
cuum. This pool was further purified by gel permeation chromatogra- 
phy on two serial columns (2.0× 100 cm each) of Bio-Gel P2 equili- 
brated in water. The elution was followed by use of R-403 Waters 
differential refractometer (RI). The fractions were tested for the pres- 
ence of Y-SLN by TLC and those containing the trisaccharide were 
pooled and freeze-dried. 
2.6. Sialylation using MU-NeuAc as donor 
The same experimental pproach as described before was used for 
sialylation using equimolar quantities (10 lamol) of MU-NeuAc and 
N-acetyllactosamine, but for the following small modification. After 
incubation and inactivation, the mixture was purified on two serial 
Sep-Pak C18 cartridges. In this way polar compounds like unreacted 
N-acetyllactosamine and Y-SLN were eluted with a polar solvent 
(water) while less polar compounds like MU and MU-NeuAc were 
eluted with a nonpolar solvent (methanol). The water-eluted fraction 
was pooled and further purified by gel permeation chromatography 
on a column (2.0 × 100 cm) of Bio-Gel P2 equilibrated in water. The 
elution was followed by use of the R-403 Waters RI detector. The 
fractions were tested for the presence of Y-SLN by TLC and those 
containing the trisaccharide were pooled and freeze-dried. 
2. Z Structural identification methods 
HPLC analyses were carried out on a Beckman HPLC system 
(GOLD Model) equipped with a UV-visible detector, monitoring at 
210 nm (N-acetyl group), and a LiChrosorb-NH2 column (5 lam, 
250×4.00 mm I.D.). The column was eluted under isocratic condi- 
tions using acetonitrile:15 mM KH2PO4 (50:50) as mobile phase. 
13@ and 1H-NMR decoupled spectra were measured on a Bruker 
AC 200 (13C 50.3 MHz, 1H 200 MHz) spectrometer using a multi- 
nuclear 5 mm probe. 500 lal of deuterated water was used for all the 
measurements with a typical sample concentration of 5 mg/ml for 1H 
measurements and 30 mg/ml for 13C measurements. The spectra were 
obtained at 37°C. 
|on spray mass spectrometry data were recorded on a API-I PE- 
SCIEX quadrupole mass spectrometer connected to a syringe pump 
for the injection of the samples. The sample was dissolved in 50% 
aqueous acetonitrile 5 mM ammonium acetate and injected at a 
flow rate of 7 gl/min. Spectra were recorded in positive ion mode 
using a step size of 0.1 ainu, an orifice potential of 90 V and an ion 
spray voltage of 5000 V. 
3. Results and discussion 
Two consecutive transglycosylat ion react ions were used for 
the synthesis o f  Y -SLN.  The N-acetyl lactosamine produced 
by the first transglycosylat ion react ion [18] was used as sub- 
strate for the sialylation by use of  the specific react ion o f  
trans-sial idase from T. cruzi (Fig. 1). Molecules o f  different 
kind were used as donors ;  one o f  them can be considered the 
'natural '  substrate (i.e. 3'-sialyl lactose) for the other. In  all 
cases we were able to obta in the desired product ,  a l though 
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Fig. 2. HPLC profiles of standard (A), transglycosylation product (B) and of a mixture of standard and transglycosylation product (C). 
i~ different yields. Using 3'-sialyllactose as a donor, a yield of 
2 ~0/,, (on a molar basis) was obtained, whereas MU-NeuAc 
~ave a molar yield of 60%. From a practical point of view, 
t~e use of synthetic substrates uch as MU-NeuAc is more 
advantageous since the procedure of synthesis of this sub- 
s~rate is well described [19] and the aglycone part (4-methyl- 
t~mbelliferone) cannot act as acceptor, thus making the reac- 
t on virtually irreversible and shifted towards the synthesis of 
3'-SLN. The apolar nature of this substrate facilitates its sep- 
aration from the reaction products by simple solid phase 
e~traction. In contrast, the 'natural' substrate 3'-sialyllactose 
7 able 1 
C chemical shifts and assignments of transglycosylation product 
( arbon atom NeuAcc~2-3 Gal~l-4 GlcNAco~ GIcNAc[3 
1 175.11 
: 101.10 
3 40.95 
4 69.55 
5 53.00 
6 74.16 
T 69.45 
~" 73.01 
9 63.91 
1 ) 176.26 
I 23.19 
(O 
(H3 
103.90 91.81 96.02 
70.62 54.99 57.54 
76.43 70.49 73.68 
68.78 80.11 79.72 
76.81 71.50 76.10 
62.25 61.31 61.43 
176.09 176.09 
23.15 23.28 
Chemical shifts are given in ppm and refer indirectly to tetramethyl- 
silane using 1,4-dioxane as internal standard (67.86 ppm). 
is difficult to obtain and/or to synthesize and can easily act as 
acceptor too. 
The characterization of the trisaccharides synthesized as 
above described was carried out by HPLC, 13C-NMR spec- 
troscopy and by ion spray mass spectrometry. For both ex- 
perimental approaches used, the obtained products have been 
unambiguously identified as 3'-SLN. In fact, the HPLC reten- 
tion times of both reaction products and of 3'-SLN corre- 
spond (Fig. 2); the 13C-NMR assignments of the spectra of 
both products match perfectly with those reported in the lit- 
erature (Table 1) [20] and the ion spray mass spectra of both 
reaction products are identical to each other and to that of a 
genuine sample of 3'-SLN, showing the ions at m/z 675.2, 
697.2, and 713.1 corresponding to [M+H] +, [M+Na] +, and 
[M+K] +. A fourth ion at m/z 719.1 corresponds to the sodium 
adduct of the trisaccharide bearing sodium as counterion (Fig. 
3). Moreover, for both products obtained using the two dif- 
ferent donors the converging evidence of HPLC, NMR and 
ion spray mass spectrometry indicates that undesired impuri- 
ties, if present, were below the analytical detection limits. 
The enzymatic synthesis of sialyl oligosaccharides in gener- 
al, and of 3'-SLN in particular, has already been reported, but 
in all cases described so far at least a galactosyltransferase 
[21,22], a sialyltransferase [23] or both [10,24] have been 
used. When either transgalactosylation [11] or transsialylation 
was used [11,25,26], low regioselectivity was obtained. The 
experimental modulation of B. circulans [3-galactosidase activ- 
ity used for the synthesis of N-acetyllactosamine [18] made it 
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Fig. 3. Positive ion spray mass spectra of standard (A) and transgly- 
cosylation product (B). 
possible to obtain a high regioselectivity ogether kvith a high 
yield of synthesis; the subsequent use of T. cruzi trans-siali- 
dase overcomes the regioselectivity problems of the transsial- 
ylation. The latter enzyme shows a better efficiency in trans- 
ferring sialic acid to saccharides with terminal ~-galactose, 
rather than hydrolyzing it. This reaction results in the forma- 
tion of the unique c~2-3 linkage between the terminal sialic 
acid and the galactose residue [14,27,28]. Few data have 
been reported on the use of trans-sialidase for synthetic goals 
[22,29,30]. Only Nishimura et al. [22] used this enzyme for 
preparative synthesis of 3'-SLN chemically linked on a 
water-soluble polyacrylamide, using MU-NeuAc as donor 
and obtaining only a 35% overall yield on a molar base. 
In conclusion, the experimental pproaches reported here 
describe the regiospecific synthesis of the trisaccharide 3'- 
SLN, confirming the importance and the potential of trans- 
glycosylation reactions for the synthesis of biologically impor- 
tant oligosaccharides starting from cheap sugars or their de- 
rivatives. In particular the data here presented are the first 
report on the complete synthesis of 3'-SLN by the exclusive 
use of highly regioselective transglycolytic reactions. 
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